Loading clinical trials...
Loading clinical trials...
A Prospective Phase II Trial of Molecular Profiling to Guide Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreas
Conditions
Interventions
Milestone 1: Targeted chemotherapy prior to surgery
Milestone 2: Chemoradiotherapy (cXRT)
+12 more
Locations
2
United States
University of Cincinnati Cancer Center
Cincinnati, Ohio, United States
Froedtert and The Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Start Date
November 1, 2011
Primary Completion Date
June 1, 2018
Completion Date
April 11, 2022
Last Updated
August 14, 2023
NCT06423326
NCT04389632
NCT04895709
NCT05825066
NCT07409272
NCT04605913
Lead Sponsor
Medical College of Wisconsin
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions